Edwards Lifesciences Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$1,553,100	$1,532,200	$1,412,700	$1,385,800
Gross Profit	1,209,600	1,189,600	1,111,100	1,093,600
EBITDA	387,600	400,200	470,500	483,700
EBIT	348,400	362,100	433,900	441,100
Net Income	291,100	329,800	358,000	385,600
Net Change In Cash	1,553,100	1,532,200	1,412,700	1,385,800
Free Cash Flow	516,200	240,900	224,400	224,400
Cash	2,685,600	3,272,800	3,140,600	3,045,200
Basic Shares	585,700	587,900	587,800	590,500

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$5,439,500	$6,004,800	$5,382,400	$5,232,500
Gross Profit	4,322,000	4,625,000	4,215,200	4,006,600
EBITDA	1,723,100	1,534,100	1,960,400	1,890,100
EBIT	1,567,900	1,534,100	1,793,600	1,726,800
Net Income	4,174,600	1,402,400	1,521,900	1,503,100
Net Change In Cash	5,439,500	6,004,800	5,382,400	5,232,500
Cost of Revenue			-114,000	-346,700
Free Cash Flow	289,900	629,500	953,400	1,402,300
Cash	3,045,200	1,132,300	769,000	862,800
Basic Shares	599,300	609,400	624,200	631,200